Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tumor Necrosis Factor Receptor Superfamily Member 18 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tumor Necrosis Factor Receptor Superfamily Member 18 by Country/Region, 2017, 2022 & 2028

2.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Type

2.2.1 AMG-228

2.2.2 BMS-986156

2.2.3 FPA-154

2.2.4 GWN-323

2.2.5 INCAGN-1876

2.2.6 Others

2.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type

2.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2017-2022)

2.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Price by Type (2017-2022)

2.4 Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Application

2.4.1 Melanoma

2.4.2 Non-Small Cell Lung Cancer

2.4.3 Gastric Cancer

2.4.4 Blood Cancer

2.4.5 Others

2.5 Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application

2.5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Market Share by Application (2017-2022)

2.5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Price by Application (2017-2022)

3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 by Company

3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Breakdown Data by Company

3.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Sales by Company (2020-2022)

3.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2020-2022)

3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Revenue by Company (2020-2022)

3.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Company (2020-2022)

3.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Company (2020-2022)

3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Price by Company

3.4 Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Location Distribution

3.4.2 Players Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tumor Necrosis Factor Receptor Superfamily Member 18 by Geographic Region

4.1 World Historic Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Geographic Region (2017-2022)

4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Revenue by Geographic Region

4.2 World Historic Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Country/Region (2017-2022)

4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Revenue by Country/Region

4.3 Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth

4.4 APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth

4.5 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth

4.6 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth

5 Americas

5.1 Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country

5.1.1 Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2017-2022)

5.1.2 Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2017-2022)

5.2 Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type

5.3 Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region

6.1.1 APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2017-2022)

6.1.2 APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2017-2022)

6.2 APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type

6.3 APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 by Country

7.1.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2017-2022)

7.1.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2017-2022)

7.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type

7.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 by Country

8.1.1 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2017-2022)

8.2 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type

8.3 Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18

10.3 Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18

10.4 Industry Chain Structure of Tumor Necrosis Factor Receptor Superfamily Member 18

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors

11.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Customer

12 World Forecast Review for Tumor Necrosis Factor Receptor Superfamily Member 18 by Geographic Region

12.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Forecast by Region

12.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Forecast by Region (2023-2028)

12.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Forecast by Type

12.7 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Forecast by Application

13 Key Players Analysis

13.1 Ablynx NV

13.1.1 Ablynx NV Company Information

13.1.2 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ablynx NV Main Business Overview

13.1.5 Ablynx NV Latest Developments

13.2 Amgen Inc

13.2.1 Amgen Inc Company Information

13.2.2 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Inc Main Business Overview

13.2.5 Amgen Inc Latest Developments

13.3 Apogenix GmbH

13.3.1 Apogenix GmbH Company Information

13.3.2 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Apogenix GmbH Main Business Overview

13.3.5 Apogenix GmbH Latest Developments

13.4 Bristol-Myers Squibb Company

13.4.1 Bristol-Myers Squibb Company Company Information

13.4.2 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bristol-Myers Squibb Company Main Business Overview

13.4.5 Bristol-Myers Squibb Company Latest Developments

13.5 Five Prime Therapeutics Inc

13.5.1 Five Prime Therapeutics Inc Company Information

13.5.2 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Five Prime Therapeutics Inc Main Business Overview

13.5.5 Five Prime Therapeutics Inc Latest Developments

13.6 Incyte Corp

13.6.1 Incyte Corp Company Information

13.6.2 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Incyte Corp Main Business Overview

13.6.5 Incyte Corp Latest Developments

13.7 MedImmune LLC

13.7.1 MedImmune LLC Company Information

13.7.2 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.7.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 MedImmune LLC Main Business Overview

13.7.5 MedImmune LLC Latest Developments

13.8 Merck & Co Inc

13.8.1 Merck & Co Inc Company Information

13.8.2 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merck & Co Inc Main Business Overview

13.8.5 Merck & Co Inc Latest Developments

13.9 Novartis AG

13.9.1 Novartis AG Company Information

13.9.2 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis AG Main Business Overview

13.9.5 Novartis AG Latest Developments

13.10 OncoMed Pharmaceuticals Inc

13.10.1 OncoMed Pharmaceuticals Inc Company Information

13.10.2 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 OncoMed Pharmaceuticals Inc Main Business Overview

13.10.5 OncoMed Pharmaceuticals Inc Latest Developments

13.11 Regeneron Pharmaceuticals Inc

13.11.1 Regeneron Pharmaceuticals Inc Company Information

13.11.2 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

13.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Regeneron Pharmaceuticals Inc Main Business Overview

13.11.5 Regeneron Pharmaceuticals Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tumor Necrosis Factor Receptor Superfamily Member 18 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of AMG-228

Table 4. Major Players of BMS-986156

Table 5. Major Players of FPA-154

Table 6. Major Players of GWN-323

Table 7. Major Players of INCAGN-1876

Table 8. Major Players of Others

Table 9. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2017-2022)

Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Type (2017-2022) & ($ million)

Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2017-2022)

Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2017-2022)

Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Application (2017-2022)

Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application (2017-2022)

Table 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Company (2020-2022)

Table 21. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Company (2020-2022)

Table 23. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Producing Area Distribution and Sales Area

Table 25. Players Tumor Necrosis Factor Receptor Superfamily Member 18 Products Offered

Table 26. Tumor Necrosis Factor Receptor Superfamily Member 18 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Geographic Region (2017-2022)

Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country/Region (2017-2022)

Table 35. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2017-2022)

Table 39. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2017-2022)

Table 41. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2017-2022)

Table 43. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2017-2022)

Table 45. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2017-2022)

Table 47. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Region (2017-2022)

Table 49. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2017-2022)

Table 51. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2017-2022)

Table 53. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2017-2022)

Table 55. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2017-2022)

Table 57. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2017-2022)

Table 59. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Tumor Necrosis Factor Receptor Superfamily Member 18

Table 70. Key Market Challenges & Risks of Tumor Necrosis Factor Receptor Superfamily Member 18

Table 71. Key Industry Trends of Tumor Necrosis Factor Receptor Superfamily Member 18

Table 72. Tumor Necrosis Factor Receptor Superfamily Member 18 Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List

Table 75. Tumor Necrosis Factor Receptor Superfamily Member 18 Customer List

Table 76. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Forecast by Region

Table 78. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share Forecast by Application (2023-2028)

Table 96. Ablynx NV Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 97. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 98. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Ablynx NV Main Business

Table 100. Ablynx NV Latest Developments

Table 101. Amgen Inc Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 102. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 103. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Amgen Inc Main Business

Table 105. Amgen Inc Latest Developments

Table 106. Apogenix GmbH Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 107. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 108. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Apogenix GmbH Main Business

Table 110. Apogenix GmbH Latest Developments

Table 111. Bristol-Myers Squibb Company Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 112. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 113. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Bristol-Myers Squibb Company Main Business

Table 115. Bristol-Myers Squibb Company Latest Developments

Table 116. Five Prime Therapeutics Inc Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 117. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 118. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Five Prime Therapeutics Inc Main Business

Table 120. Five Prime Therapeutics Inc Latest Developments

Table 121. Incyte Corp Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 122. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 123. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Incyte Corp Main Business

Table 125. Incyte Corp Latest Developments

Table 126. MedImmune LLC Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 127. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 128. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. MedImmune LLC Main Business

Table 130. MedImmune LLC Latest Developments

Table 131. Merck & Co Inc Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 132. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 133. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Merck & Co Inc Main Business

Table 135. Merck & Co Inc Latest Developments

Table 136. Novartis AG Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 137. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 138. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Novartis AG Main Business

Table 140. Novartis AG Latest Developments

Table 141. OncoMed Pharmaceuticals Inc Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 142. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 143. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. OncoMed Pharmaceuticals Inc Main Business

Table 145. OncoMed Pharmaceuticals Inc Latest Developments

Table 146. Regeneron Pharmaceuticals Inc Basic Information, Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturing Base, Sales Area and Its Competitors

Table 147. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offered

Table 148. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. Regeneron Pharmaceuticals Inc Main Business

Table 150. Regeneron Pharmaceuticals Inc Latest Developments

List of Figures

Figure 1. Picture of Tumor Necrosis Factor Receptor Superfamily Member 18

Figure 2. Tumor Necrosis Factor Receptor Superfamily Member 18 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of AMG-228

Figure 10. Product Picture of BMS-986156

Figure 11. Product Picture of FPA-154

Figure 12. Product Picture of GWN-323

Figure 13. Product Picture of INCAGN-1876

Figure 14. Product Picture of Others

Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Type in 2021

Figure 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Type (2017-2022)

Figure 17. Tumor Necrosis Factor Receptor Superfamily Member 18 Consumed in Melanoma

Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Melanoma (2017-2022) & (K Pcs)

Figure 19. Tumor Necrosis Factor Receptor Superfamily Member 18 Consumed in Non-Small Cell Lung Cancer

Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Non-Small Cell Lung Cancer (2017-2022) & (K Pcs)

Figure 21. Tumor Necrosis Factor Receptor Superfamily Member 18 Consumed in Gastric Cancer

Figure 22. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Gastric Cancer (2017-2022) & (K Pcs)

Figure 23. Tumor Necrosis Factor Receptor Superfamily Member 18 Consumed in Blood Cancer

Figure 24. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Blood Cancer (2017-2022) & (K Pcs)

Figure 25. Tumor Necrosis Factor Receptor Superfamily Member 18 Consumed in Others

Figure 26. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Others (2017-2022) & (K Pcs)

Figure 27. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Application (2017-2022)

Figure 28. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Application in 2021

Figure 29. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Company in 2021

Figure 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Geographic Region in 2021

Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region (2017-2022)

Figure 34. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country/Region in 2021

Figure 35. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2017-2022 (K Pcs)

Figure 36. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2017-2022 ($ Millions)

Figure 37. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2017-2022 (K Pcs)

Figure 38. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2017-2022 ($ Millions)

Figure 39. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2017-2022 (K Pcs)

Figure 40. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue 2017-2022 ($ Millions)

Figure 43. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country in 2021

Figure 44. Americas Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country in 2021

Figure 45. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Region in 2021

Figure 50. APAC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Regions in 2021

Figure 51. China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country in 2021

Figure 58. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country in 2021

Figure 59. Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share by Country in 2021

Figure 66. Egypt Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18 in 2021

Figure 72. Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 18

Figure 73. Industry Chain Structure of Tumor Necrosis Factor Receptor Superfamily Member 18

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles